Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

Vaccine
Marie-Josée J MangenHester de Melker

Abstract

This study assessed whether the inclusion of two rotavirus (RV) vaccines in the Dutch national immunization programme is cost-effective. Costs and outcomes in unvaccinated and vaccinated populations are compared for a time period of 20 years. In the baseline, assuming competitive market forces in relation to vaccine costs, Rotarix is more cost-effective than RotaTeq, resulting in a cost-utility ratio (CUR) of euro 53,000 per DALY (third payer perspective) and euro 49,000 per DALY (societal perspective), but both considered as being not cost-effective. Vaccine-related costs, annual epidemic-size, and indirect protection are the major factors that determine cost-effectiveness of RV vaccination.

References

May 1, 1992·Social Science & Medicine·M A Koopmanschap, B M van Ineveld
May 8, 1995·Journal of Health Economics·M A KoopmanschapL van Roijen
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A de WitY T van Duynhoven
Feb 24, 2001·Epidemiology and Infection·A H HavelaarE van Kempen
Oct 3, 2001·American Journal of Epidemiology·M A de WitY T van Duynhoven
Jan 29, 2002·Epidemiology and Infection·M A de WitY T van Duynhoven
Mar 5, 2003·Epidemiology and Infection·J A RobertsUNKNOWN Infectious Intestinal Disease Study Executive
Jan 15, 2004·Emerging Infectious Diseases·Matty A S de WitYvonne T H P van Duynhoven
Apr 6, 2004·Epidemiology and Infection·W E van den BrandhofY T H P van Duynhoven
Jun 11, 2004·Epidemiology and Infection·A H HavelaarN C van de Kar
Feb 24, 2005·Epidemiology and Infection·Y T H P van DuynhovenUNKNOWN eXplosie Project Team
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
Jan 6, 2006·The New England Journal of Medicine·Roger I Glass, Umesh D Parashar
Jan 7, 2006·The Pediatric Infectious Disease Journal·Ulrich DesselbergerTimo Vesikari
Jan 7, 2006·The Pediatric Infectious Disease Journal·Timo VesikariHans-Iko Huppertz
Jun 29, 2006·The Pediatric Infectious Disease Journal·H Fred ClarkPenny M Heaton
Jun 8, 2007·Emerging Infectious Diseases·Thea Kølsen FischerAnders Paerregaard
Nov 21, 2007·Vaccine·Anthony T NewallC Raina MacIntyre
Apr 10, 2008·BMC Public Health·Ana López-de-AndrésAngel Gil de Miguel
Oct 25, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joke BilckePhilippe Beutels
Jul 18, 2009·Science·Graham F Medley, D James Nokes

❮ Previous
Next ❯

Citations

May 16, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M S CorcoranI H M van Loo
Jun 15, 2011·BMC Public Health·Mark H RozenbaumUNKNOWN Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group)
Jul 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I H M FriesemaY T H P van Duynhoven
Jan 10, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I H M FriesemaUNKNOWN GEops Working Group
Oct 12, 2010·Vaccine·Hans HouwelingUNKNOWN National Immunisation Programme Review Committee of the Health Council of the Netherlands
Dec 17, 2014·Epidemiology and Infection·A J J M OostvogelsM-J J Mangen
Jan 19, 2016·Population Health Metrics·Juanita A HaagsmaJoshua A Salomon
Apr 11, 2013·Human Vaccines & Immunotherapeutics·Samuel AballéaMondher Toumi
May 28, 2014·Human Vaccines & Immunotherapeutics·Richard RheingansJacob Atem
May 16, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tjalke A WestraMaarten J Postma
Sep 25, 2012·Vaccine·Katherine E AtkinsAlison P Galvani
May 1, 2013·Vaccine·David N FismanMonika Naus
Dec 24, 2013·Preventive Medicine·Iñaki ImazJesús González-Enríquez
Aug 4, 2009·Risk Analysis : an Official Publication of the Society for Risk Analysis·Robin J LakeElisabeth Oakley
Apr 29, 2020·International Journal of Technology Assessment in Health Care·Xue FengDaniel A Ollendorf
Nov 20, 2014·Journal of Korean Medical Science·Kyoung Ae KongKyung-Hyo Kim
Apr 27, 2018·European Journal of Public Health·Mark R O'DonovanClaudia Stein
Oct 21, 2016·Human Vaccines & Immunotherapeutics·Shu-Ling HoshiIchiro Okubo
Oct 16, 2020·The Pediatric Infectious Disease Journal·Teruyoshi KurosawaKenzo Takahashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.